Galectin Therapeutics | Beban Penjualan Dan Administrasi

Selling And Administration Expenses Perubahan Tanggal
AbbVie USD 3.61B 273M 2023-12
Bristol-Myers Squibb USD 2.06B 126M 2023-12
Galectin Therapeutics USD 1.33M 101K 2023-12
Gilead Sciences USD 1.61B 293M 2023-12
Immunic USD 3.77M 75K 2023-09
Incyte USD 293.86M 25.97M 2023-12
Merck USD 2.75B 272M 2023-12
Regulus Therapeutics USD 2.64M 298K 2023-09



Galectin Therapeutics Beban Penjualan Dan Administrasi - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - Apr 2024.